Cargando…
Validations of Top and Novel Susceptibility Variants in All-Age Chinese Patients With Acute Lymphoblastic Leukemia
Through genome-wide association studies (GWAS), multiple inherited predispositions to acute lymphoblastic leukemia (ALL) have been identified in children. Most recently, a novel susceptibility locus at ERG was localized, exhibiting Hispanic-specific manner. In this study, we conducted a replication...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477633/ https://www.ncbi.nlm.nih.gov/pubmed/33193587 http://dx.doi.org/10.3389/fgene.2020.01004 |
_version_ | 1783579942731120640 |
---|---|
author | Liao, Fei Ye, Yuanxin Yin, Dandan Qin, Yun Zhao, Jiangyan Zhang, Wanhua Zhang, Yan Deng, Zhujun Wang, Yuelan Ying, Binwu Wang, Lanlan Gao, Ju Shu, Yang Zhu, Yiping Lu, Xiaoxi |
author_facet | Liao, Fei Ye, Yuanxin Yin, Dandan Qin, Yun Zhao, Jiangyan Zhang, Wanhua Zhang, Yan Deng, Zhujun Wang, Yuelan Ying, Binwu Wang, Lanlan Gao, Ju Shu, Yang Zhu, Yiping Lu, Xiaoxi |
author_sort | Liao, Fei |
collection | PubMed |
description | Through genome-wide association studies (GWAS), multiple inherited predispositions to acute lymphoblastic leukemia (ALL) have been identified in children. Most recently, a novel susceptibility locus at ERG was localized, exhibiting Hispanic-specific manner. In this study, we conducted a replication study to in all-age Chinese patients (N = 451), not only validating the novel ERG locus, but also systematically determining the impact of age on association status of the top GWAS signals. We found that single nucleotide polymorphisms at ARID5B, IKZF1, CEBPE, PIP4K2A were only significantly associated with ALL susceptibility in childhood patients with no BCR-ABL fusion, while GATA3 signal exhibited its significance in adults no matter carrying BCR-ABL fusion or not. Moreover, the novel ERG SNP can be validated in pediatric patients without both BCR-ABL and ETV6-RUNX1 fusion. Our finding suggests the modifying effects of age on genetic predisposition to ALL, and highlights the impact of ERG SNP in Chinese patients. |
format | Online Article Text |
id | pubmed-7477633 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-74776332020-11-12 Validations of Top and Novel Susceptibility Variants in All-Age Chinese Patients With Acute Lymphoblastic Leukemia Liao, Fei Ye, Yuanxin Yin, Dandan Qin, Yun Zhao, Jiangyan Zhang, Wanhua Zhang, Yan Deng, Zhujun Wang, Yuelan Ying, Binwu Wang, Lanlan Gao, Ju Shu, Yang Zhu, Yiping Lu, Xiaoxi Front Genet Genetics Through genome-wide association studies (GWAS), multiple inherited predispositions to acute lymphoblastic leukemia (ALL) have been identified in children. Most recently, a novel susceptibility locus at ERG was localized, exhibiting Hispanic-specific manner. In this study, we conducted a replication study to in all-age Chinese patients (N = 451), not only validating the novel ERG locus, but also systematically determining the impact of age on association status of the top GWAS signals. We found that single nucleotide polymorphisms at ARID5B, IKZF1, CEBPE, PIP4K2A were only significantly associated with ALL susceptibility in childhood patients with no BCR-ABL fusion, while GATA3 signal exhibited its significance in adults no matter carrying BCR-ABL fusion or not. Moreover, the novel ERG SNP can be validated in pediatric patients without both BCR-ABL and ETV6-RUNX1 fusion. Our finding suggests the modifying effects of age on genetic predisposition to ALL, and highlights the impact of ERG SNP in Chinese patients. Frontiers Media S.A. 2020-08-25 /pmc/articles/PMC7477633/ /pubmed/33193587 http://dx.doi.org/10.3389/fgene.2020.01004 Text en Copyright © 2020 Liao, Ye, Yin, Qin, Zhao, Zhang, Zhang, Deng, Wang, Ying, Wang, Gao, Shu, Zhu and Lu. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Genetics Liao, Fei Ye, Yuanxin Yin, Dandan Qin, Yun Zhao, Jiangyan Zhang, Wanhua Zhang, Yan Deng, Zhujun Wang, Yuelan Ying, Binwu Wang, Lanlan Gao, Ju Shu, Yang Zhu, Yiping Lu, Xiaoxi Validations of Top and Novel Susceptibility Variants in All-Age Chinese Patients With Acute Lymphoblastic Leukemia |
title | Validations of Top and Novel Susceptibility Variants in All-Age Chinese Patients With Acute Lymphoblastic Leukemia |
title_full | Validations of Top and Novel Susceptibility Variants in All-Age Chinese Patients With Acute Lymphoblastic Leukemia |
title_fullStr | Validations of Top and Novel Susceptibility Variants in All-Age Chinese Patients With Acute Lymphoblastic Leukemia |
title_full_unstemmed | Validations of Top and Novel Susceptibility Variants in All-Age Chinese Patients With Acute Lymphoblastic Leukemia |
title_short | Validations of Top and Novel Susceptibility Variants in All-Age Chinese Patients With Acute Lymphoblastic Leukemia |
title_sort | validations of top and novel susceptibility variants in all-age chinese patients with acute lymphoblastic leukemia |
topic | Genetics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477633/ https://www.ncbi.nlm.nih.gov/pubmed/33193587 http://dx.doi.org/10.3389/fgene.2020.01004 |
work_keys_str_mv | AT liaofei validationsoftopandnovelsusceptibilityvariantsinallagechinesepatientswithacutelymphoblasticleukemia AT yeyuanxin validationsoftopandnovelsusceptibilityvariantsinallagechinesepatientswithacutelymphoblasticleukemia AT yindandan validationsoftopandnovelsusceptibilityvariantsinallagechinesepatientswithacutelymphoblasticleukemia AT qinyun validationsoftopandnovelsusceptibilityvariantsinallagechinesepatientswithacutelymphoblasticleukemia AT zhaojiangyan validationsoftopandnovelsusceptibilityvariantsinallagechinesepatientswithacutelymphoblasticleukemia AT zhangwanhua validationsoftopandnovelsusceptibilityvariantsinallagechinesepatientswithacutelymphoblasticleukemia AT zhangyan validationsoftopandnovelsusceptibilityvariantsinallagechinesepatientswithacutelymphoblasticleukemia AT dengzhujun validationsoftopandnovelsusceptibilityvariantsinallagechinesepatientswithacutelymphoblasticleukemia AT wangyuelan validationsoftopandnovelsusceptibilityvariantsinallagechinesepatientswithacutelymphoblasticleukemia AT yingbinwu validationsoftopandnovelsusceptibilityvariantsinallagechinesepatientswithacutelymphoblasticleukemia AT wanglanlan validationsoftopandnovelsusceptibilityvariantsinallagechinesepatientswithacutelymphoblasticleukemia AT gaoju validationsoftopandnovelsusceptibilityvariantsinallagechinesepatientswithacutelymphoblasticleukemia AT shuyang validationsoftopandnovelsusceptibilityvariantsinallagechinesepatientswithacutelymphoblasticleukemia AT zhuyiping validationsoftopandnovelsusceptibilityvariantsinallagechinesepatientswithacutelymphoblasticleukemia AT luxiaoxi validationsoftopandnovelsusceptibilityvariantsinallagechinesepatientswithacutelymphoblasticleukemia |